GALATEA BIO INC
MIAMI LAKES, FL · Founded 2021 · CIK 0002036550 · Biotech · Private
Polygenic Risk Score models and ancestry reference panels for genetic disease risk prediction across diverse populations
galatea.bio →- Grants
- $399K
- 1 award
- Sector median: 1
- Raised
- $3.7M
- 1 Form D · Sep 2024
- 25 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 0 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20242025
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $3,656,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development and application of machine learning-based approaches for estimating disease risk in diverse and admixed populations. | $399,156 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2299 | Cyclacel Pharmaceuticals, Inc. | — | $36M |
| 2300 | Retrotope, Inc. | — | $32M |
| 2301 | Basking Biosciences | — | $29M |
| 2302 | GALATEA BIO INC | — | $3.7M |
| 2303 | Relay Therapeutics | — | $30M |
| 2304 | Acurx Pharmaceuticals, Inc. | — | $17M |
| 2305 | Congruence Therapeutics | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Wale AyeniDirector
- Carlos BustamanteDirector · Executive Officer
- Cindy CheungDirector
- Alexander IoannidisDirector
- Nicholas KatsanisDirector
- Mohit KaushalDirector
- Muzammil MansuriDirector
- Arthur PolkExecutive Officer
Patents
- Methods And Systems For Detecting Familial Hypercholesterolemia And Related Disordersapplication
- Methods And Systems For Detecting Familial Hypercholesterolemia And Related Disordersapplication
- Ancestry-adjusted Polygenic Risk Score (prs) Models And Model Pipelineapplication
- Ancestry-adjusted Polygenic Risk Score (prs) Models And Model Pipelineapplication
- Ancestry-adjusted Polygenic Risk Score (prs) Models And Model Pipelineapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.